Evidence map›Paper›PMID 38046277›Full record

ArticleBMJ open sport & exercise medicine2023

Periodic health evaluation in athletes competing in Tokyo 2020: from SARS-CoV-2 to Olympic medals.

Maria Rosaria Squeo, Sara Monosilio, Alessandro Gismondi, Marco Perrone, Emanuele Gregorace, Erika Lemme, Giuseppe Di Gioia, Ruggiero Mango, Silvia Prosperi, Antonio Spataro and 3 more

Abstract read
In one paragraph

Article in BMJ open sport & exercise medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Maria Rosaria SqueoItalian National Olympic Committee, Institute of Sport Medicine and Science, Roma, Italy.
Sara MonosilioItalian National Olympic Committee, Institute of Sport Medicine and Science, Roma, Italy.ORCID 0000-0001-5960-7980
Alessandro GismondiItalian National Olympic Committee, Institute of Sport Medicine and Science, Roma, Italy.
Marco PerroneItalian National Olympic Committee, Institute of Sport Medicine and Science, Roma, Italy.
Emanuele GregoraceItalian National Olympic Committee, Institute of Sport Medicine and Science, Roma, Italy.
Erika LemmeItalian National Olympic Committee, Institute of Sport Medicine and Science, Roma, Italy.ORCID 0000-0001-8307-8118
Giuseppe Di GioiaItalian National Olympic Committee, Institute of Sport Medicine and Science, Roma, Italy.ORCID 0000-0002-9158-5440
Ruggiero MangoItalian National Olympic Committee, Institute of Sport Medicine and Science, Roma, Italy.
Silvia ProsperiItalian National Olympic Committee, Institute of Sport Medicine and Science, Roma, Italy.
Antonio SpataroItalian National Olympic Committee, Institute of Sport Medicine and Science, Roma, Italy.
Viviana MaestriniItalian National Olympic Committee, Institute of Sport Medicine and Science, Roma, Italy.
Barbara Di GiacintoItalian National Olympic Committee, Institute of Sport Medicine and Science, Roma, Italy.
Antonio PellicciaItalian National Olympic Committee, Institute of Sport Medicine and Science, Roma, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The Tokyo Olympic games were the only games postponed for a year in peacetime, which will be remembered as the COVID-19 Olympics. No data are currently available on the effect on athlete's performance. Aim: To examine the Italian Olympic athletes who have undergone the return to play (RTP) protocol after COVID-19 and their Olympic results. Methods: 642 Potential Olympics (PO) athletes competing in 19 summer sport disciplines were evaluated through a preparticipation screening protocol and, when necessary, with the RTP protocol. The protocol comprised blood tests, 12-lead resting ECG, transthoracic echocardiogram, cardiopulmonary exercise test, 24-hour Holter-ECG monitoring and cardiovascular MR based on clinical indication. Results: Of the 642 PO athletes evaluated, 384 participated at the Olympic Games, 254 being excluded for athletic reasons. 120 athletes of the total cohort of 642 PO were affected by COVID-19. They were evaluated with the RTP protocol before resuming physical activity after a mean detraining period of 30±13 days. Of them, 100 were selected for Olympic Games participation, 16 were excluded for athletic reasons and 4 were due to RTP results (2 for COVID-19-related myocarditis, 1 for pericarditis and 1 for complex ventricular arrhythmias). Among athletes with a history of COVID-19 allowed to resume physical activity after the RTP and selected for the Olympic Games, no one had abnormalities in cardiopulmonary exercise test parameters, and 28 became medal winners with 6 gold, 6 silver and 19 bronze medals. Conclusions: Among athletes with COVID-19, there is a low prevalence of cardiac sequelae. For those athletes allowed to resume physical activity after the RTP evaluation, the infection and the forced period of inactivity didn't have a negative impact on athletic performance.

Indexed as

AthleteCOVID-19Elite performanceOlympicsSports & exercise medicine

Identifiers

PMID38046277
PMCPMC10689352

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.